A Prospective Study on the Factors Sustaining Tobacco Abstinence in Patients Treated With Radio-chemotherapy or Radiotherapy Alone for Head and Neck or Lung Cancer
The TABAC STOP ORL POUMON study aims to evaluate the factors influencing long-term smoking cessation in patients with head and neck cancer (HNC) or lung cancer undergoing radiotherapy or chemoradiotherapy. This is a single-center observational study, following patients at 1, 6, and 12 months after treatment completion. The primary objective is to determine the proportion of abstinent patients at 6 months, while secondary objectives analyze factors influencing abstinence, smoking trajectories, and reasons for relapse. A total of 100 patients will be included to ensure robust statistical analysis.
• Patient aged 18 years or older
• Diagnosed with head and neck cancer or lung cancer
• Undergoing curative treatment with chemoradiotherapy, radiotherapy alone, or stereotactic radiotherapy
• Current or former smoker
• Patient covered by a social security scheme
• Patient informed and having given consent for data collection
⁃ Patients with human papillomavirus (HPV) may also be included